Location History:
- Salt Lake City, UT (US) (2003)
- Sandy, UT (US) (2001 - 2016)
Company Filing History:
6 out of 16 
2 out of 4 
2 out of 6 
Years Active: 2001-2016
Title: **Innovative Contributions of Chung Shih in Biodegradable Drug Delivery Systems**
Introduction
Chung Shih, an accomplished inventor based in Sandy, Utah, has made significant strides in the field of drug delivery systems. With a remarkable portfolio of 12 patents, his innovative work focuses on biodegradable compositions that enhance the efficacy of drug administration.
Latest Patents
Shih’s latest patents include a groundbreaking formulation titled "Biodegradable block copolymeric compositions for drug delivery." This invention showcases an improved drug delivery composition that incorporates biodegradable block copolymer drug carriers along with polyethylene glycol (PEG) or its derivatives. This composition can either be administered directly or after rapid reconstitution in an aqueous vehicle, resulting in a uniform colloidal system. Another pivotal patent is "Compositions and methods for enhancing active agent absorption," which presents methods for increasing the absorption of active agents across the mucosal barriers in animal subjects, as well as providing various methods of administration and dosage forms.
Career Highlights
Throughout his career, Chung Shih has contributed to the field through his tenure at reputable companies such as Macromed Incorporated and Protherics Salt Lake City, Inc. His work within these firms has allowed him to develop advanced drug delivery technologies that hold promise for future pharmaceutical applications.
Collaborations
Chung has collaborated with notable coworkers including Gaylen M Zentner and Ai-Zhi Piao. These partnerships have fostered a productive environment for innovation and the development of new drug delivery solutions, further cementing Shih's reputation in the industry.
Conclusion
Chung Shih's contributions to the field of drug delivery systems through his inventive patents highlight his commitment to advancing pharmaceutical technology. His innovative approaches and collaborations continue to pave the way for enhanced therapeutic strategies, solidifying his place as a leading inventor in the biotechnological arena.